je.st
news
Home
› MYOS Corporation Announces Agreement With Cloud Pharmaceuticals, Inc. To Develop Small Molecules Targeting Sarcopenia And Cachexia
MYOS Corporation Announces Agreement With Cloud Pharmaceuticals, Inc. To Develop Small Molecules Targeting Sarcopenia And Cachexia
2014-07-30 10:12:15| drugdiscoveryonline Home Page
MYOS Corporation("MYOS" or the "Company") (NASDAQ: MYOS), an emerging biotherapeutics and bionutrition company focused on the discovery, development and commercialization of products that improve muscle health and performance, announced today that it has entered into a research and development agreement with Cloud Pharmaceuticals, Inc
Tags: small
agreement
corporation
develop
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||